Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maengjo Kim

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Molecular and Cellular Cardiology|December 15, 2010
Targeting AMPK for cardiac protection: opportunities and challengesMaengjo Kim, Rong Tian
Journal of Molecular and Cellular Cardiology|July 14, 2012
Transcript variant dictates Prkag2 cardiomyopathy?Maengjo Kim, Rong Tian
Journal of Molecular and Cellular Cardiology|February 9, 2012
AMPK isoform expression in the normal and failing heartsMaengjo Kim, Mei Shen, Soeun Ngoy, et al.
Human Genetics|May 29, 2016
De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathyPamela A Long, Michael T Zimmermann, Maengjo Kim, et al.
Journal of Molecular and Cellular Cardiology|July 4, 2008
Role of resistin in cardiac contractility and hypertrophyMaengjo Kim, Jae Kyun Oh, Susumu Sakata, et al.
Development (Cambridge, England)|November 13, 2016
Exon- and contraction-dependent functions of titin in sarcomere assemblyYu-Huan Shih, Alexey V Dvornikov, Ping Zhu, et al.
Circulation Research|August 25, 2017
Activation of γ2-AMPK Suppresses Ribosome Biogenesis and Protects Against Myocardial Ischemia/Reperfusion InjuryYang Cao, Naveen Bojjireddy, Maengjo Kim, et al.
Plos One|August 4, 2009
Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2aIoannis Karakikes, Maengjo Kim, Lahouaria Hadri, et al.
Circulation. Genomic and Precision Medicine|May 18, 2021
Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT SyndromeMaengjo Kim, Dan Ye, C S John Kim, et al.
Heart Rhythm|January 7, 2023
SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongationMaengjo Kim, Philip T Sager, David J Tester, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Molecular and Cellular Cardiology|December 15, 2010
Targeting AMPK for cardiac protection: opportunities and challengesMaengjo Kim, Rong Tian
Journal of Molecular and Cellular Cardiology|July 14, 2012
Transcript variant dictates Prkag2 cardiomyopathy?Maengjo Kim, Rong Tian
Journal of Molecular and Cellular Cardiology|February 9, 2012
AMPK isoform expression in the normal and failing heartsMaengjo Kim, Mei Shen, Soeun Ngoy, et al.
Human Genetics|May 29, 2016
De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathyPamela A Long, Michael T Zimmermann, Maengjo Kim, et al.
Journal of Molecular and Cellular Cardiology|July 4, 2008
Role of resistin in cardiac contractility and hypertrophyMaengjo Kim, Jae Kyun Oh, Susumu Sakata, et al.
Development (Cambridge, England)|November 13, 2016
Exon- and contraction-dependent functions of titin in sarcomere assemblyYu-Huan Shih, Alexey V Dvornikov, Ping Zhu, et al.
Circulation Research|August 25, 2017
Activation of γ2-AMPK Suppresses Ribosome Biogenesis and Protects Against Myocardial Ischemia/Reperfusion InjuryYang Cao, Naveen Bojjireddy, Maengjo Kim, et al.
Plos One|August 4, 2009
Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2aIoannis Karakikes, Maengjo Kim, Lahouaria Hadri, et al.
Circulation. Genomic and Precision Medicine|May 18, 2021
Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT SyndromeMaengjo Kim, Dan Ye, C S John Kim, et al.
Heart Rhythm|January 7, 2023
SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongationMaengjo Kim, Philip T Sager, David J Tester, et al.
Pageof 2